FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

387042001: Dextropropoxyphene (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461220016 Dextropropoxyphene (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481156018 Dextropropoxyphene en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2672762016 Propoxyphene en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4497501000005119 Dextropropoxyphen da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dextropropoxyphene (substance) Is a Opiatagonist/-antagonist false Inferred relationship Some
Dextropropoxyphene (substance) Is a Methadone analog (substance) true Inferred relationship Some
Dextropropoxyphene (substance) Is a Drug allergen false Inferred relationship Some
Dextropropoxyphene (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Opioid receptor agonist (disposition) true Inferred relationship Some
Dextropropoxyphene (substance) Is a Propionate true Inferred relationship Some
Dextropropoxyphene (substance) Is a Amine and/or amine derivative true Inferred relationship Some
Dextropropoxyphene (substance) Is a Carboxylic ester (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Dextropropoxyphene measurement Component True Dextropropoxyphene (substance) Inferred relationship Some 1
Product containing dextropropoxyphene (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Poisoning by co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Deliberate overdose of co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
forgiftning med co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
accidentel forgiftning med co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
tilsigtet forgiftning med co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
forgiftning med co-proxamol, uvist med hvilken hensigt Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
Accidental poisoning by co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Intentional poisoning by co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Poisoning by co-proxamol of undetermined intent Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene poisoning Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
Accidental dextropropoxyphene poisoning Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Intentional dextropropoxyphene poisoning Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
forgiftning med dextropropoxyphen, uvist med hvilken hensigt Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
Dextropropoxyphene adverse reaction Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
Allergy to propoxyphene Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
overdosis af paracetamol og dextropropoxyphen Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
accidentel overdosis af paracetamol og dextropropoxyphen Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 2
tilsigtet overdosis af paracetamol og dextropropoxyphen Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
overdosis af paracetamol og dextropropoxyphen, uvist med hvilken hensigt Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
Overdose of co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Accidental overdose by co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Overdose of co-proxamol of undetermined intent Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene overdose Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
Accidental dextropropoxyphene overdose Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
Intentional dextropropoxyphene overdose Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
overdosis af dextropropoxyphen, uvist med hvilken hensigt Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
allergi over for co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Product containing precisely dextropropoxyphene hydrochloride 65 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Product containing precisely dextropropoxyphene napsylate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Urine dextropropoxyphene level (procedure) Component False Dextropropoxyphene (substance) Inferred relationship Some 2
måling af propoxyphen Component False Dextropropoxyphene (substance) Inferred relationship Some
acetylsalicylsyre + caffein + propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
paracetamol + propoxyphennapsylat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
propoxyphenhydrochlorid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
propoxyphennapsylat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene napsylate 100 mg and paracetamol 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
accidentel forgiftning med co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 2
tilsigtet forgiftning med co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 1
Accidental poisoning by co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Intentional poisoning by co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some
Accidental dextropropoxyphene poisoning Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
Intentional dextropropoxyphene poisoning Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
co-proxamol 32,5 mg + 325 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
acetaminophen+dextropropoxyphenhydrochlorid sukkerfri suspension 325 mg/32,5mg/5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Product containing dextropropoxyphene and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene hydrochloride Is a False Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene napsylate Is a False Dextropropoxyphene (substance) Inferred relationship Some
Urine propoxyphene screening test (procedure) Component False Dextropropoxyphene (substance) Inferred relationship Some 2
Quantitative measurement of mass concentration of dextropropoxyphene in serum or plasma specimen using gas chromatography mass spectrometry technique (procedure) Component False Dextropropoxyphene (substance) Inferred relationship Some 2
Allergy to propoxyphene Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 2
allergi over for co-proxamol Causative agent False Dextropropoxyphene (substance) Inferred relationship Some 2
co-proxamol 32,5 mg + 325 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some 1
co-proxamol 32,5 mg + 325 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Dextropropoxyphene (substance) Inferred relationship Some 1
Dextropropoxyphene hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dextropropoxyphene (substance) Inferred relationship Some
Dextropropoxyphene napsylate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Dextropropoxyphene (substance) Inferred relationship Some
Acetaminophen+dextropropoxyphene hydrochloride 325mg/32.5mg/5mL conventional release oral suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dextropropoxyphene (substance) Inferred relationship Some
co-proxamol 32,5 mg + 325 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Dextropropoxyphene (substance) Inferred relationship Some 1
Product containing aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 2
Dextropropoxyphene- and paracetamol-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Dextropropoxyphene-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Product containing aspirin and caffeine and dextropropoxyphene (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 2
Aspirin and caffeine and dextropropoxyphene only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 2
Dextropropoxyphene only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Product containing only dextropropoxyphene and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Dextropropoxyphene only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Product containing only aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 2
Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dextropropoxyphene (substance) Inferred relationship Some 1
Allergy to propoxyphene Causative agent True Dextropropoxyphene (substance) Inferred relationship Some 1
Quantitative measurement of mass concentration of dextropropoxyphene in serum or plasma specimen using gas chromatography mass spectrometry technique (procedure) Component True Dextropropoxyphene (substance) Inferred relationship Some 1
Urine dextropropoxyphene level (procedure) Component True Dextropropoxyphene (substance) Inferred relationship Some 1
Urine propoxyphene screening test (procedure) Component True Dextropropoxyphene (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start